ミズホメディーの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/05/23 | 1,500 | 1,509 | 1,497 | 1,501 | +6 | +0.4% | 48,400 |
| 2025/05/22 | 1,493 | 1,499 | 1,487 | 1,495 | -7 | -0.5% | 47,900 |
| 2025/05/21 | 1,496 | 1,506 | 1,489 | 1,502 | +12 | +0.8% | 108,000 |
| 2025/05/20 | 1,505 | 1,505 | 1,484 | 1,490 | -3 | -0.2% | 46,800 |
| 2025/05/19 | 1,495 | 1,498 | 1,485 | 1,493 | +4 | +0.3% | 33,000 |
| 2025/05/16 | 1,487 | 1,490 | 1,478 | 1,489 | -4 | -0.3% | 46,900 |
| 2025/05/15 | 1,493 | 1,496 | 1,484 | 1,493 | ±0 | ±0% | 35,300 |
| 2025/05/14 | 1,497 | 1,499 | 1,482 | 1,493 | -8 | -0.5% | 49,000 |
| 2025/05/13 | 1,505 | 1,506 | 1,496 | 1,501 | -8 | -0.5% | 63,000 |
| 2025/05/12 | 1,504 | 1,510 | 1,499 | 1,509 | +5 | +0.3% | 46,200 |
| 2025/05/09 | 1,509 | 1,518 | 1,496 | 1,504 | ±0 | ±0% | 87,400 |
| 2025/05/08 | 1,502 | 1,505 | 1,497 | 1,504 | +2 | +0.1% | 38,900 |
| 2025/05/07 | 1,509 | 1,509 | 1,500 | 1,502 | -1 | -0.1% | 26,900 |
| 2025/05/02 | 1,507 | 1,512 | 1,496 | 1,503 | -4 | -0.3% | 42,500 |
| 2025/05/01 | 1,514 | 1,514 | 1,498 | 1,507 | +2 | +0.1% | 38,800 |
| 2025/04/30 | 1,515 | 1,515 | 1,500 | 1,505 | ±0 | ±0% | 36,300 |
| 2025/04/28 | 1,505 | 1,513 | 1,505 | 1,505 | ±0 | ±0% | 38,800 |
| 2025/04/25 | 1,510 | 1,510 | 1,497 | 1,505 | +9 | +0.6% | 76,300 |
| 2025/04/24 | 1,498 | 1,505 | 1,492 | 1,496 | +6 | +0.4% | 51,200 |
| 2025/04/23 | 1,500 | 1,500 | 1,487 | 1,490 | +5 | +0.3% | 33,700 |
| 2025/04/22 | 1,475 | 1,492 | 1,468 | 1,485 | +8 | +0.5% | 52,700 |
| 2025/04/21 | 1,489 | 1,499 | 1,471 | 1,477 | -3 | -0.2% | 46,700 |
| 2025/04/18 | 1,477 | 1,482 | 1,465 | 1,480 | +17 | +1.2% | 36,000 |
| 2025/04/17 | 1,470 | 1,475 | 1,452 | 1,463 | +7 | +0.5% | 27,100 |
| 2025/04/16 | 1,456 | 1,474 | 1,450 | 1,456 | +4 | +0.3% | 40,000 |
| 2025/04/15 | 1,450 | 1,465 | 1,450 | 1,452 | -1 | -0.1% | 57,700 |
| 2025/04/14 | 1,462 | 1,465 | 1,453 | 1,453 | +9 | +0.6% | 30,600 |
| 2025/04/11 | 1,430 | 1,446 | 1,426 | 1,444 | -22 | -1.5% | 57,000 |
| 2025/04/10 | 1,470 | 1,478 | 1,447 | 1,466 | +61 | +4.3% | 78,000 |
| 2025/04/09 | 1,416 | 1,422 | 1,387 | 1,405 | -30 | -2.1% | 124,000 |
| 2025/04/08 | 1,423 | 1,444 | 1,408 | 1,435 | +62 | +4.5% | 118,800 |
| 2025/04/07 | 1,372 | 1,409 | 1,341 | 1,373 | -89 | -6.1% | 203,800 |
| 2025/04/04 | 1,467 | 1,480 | 1,441 | 1,462 | -25 | -1.7% | 164,700 |
| 2025/04/03 | 1,482 | 1,498 | 1,475 | 1,487 | -18 | -1.2% | 107,000 |
| 2025/04/02 | 1,517 | 1,517 | 1,505 | 1,505 | -6 | -0.4% | 55,200 |
| 2025/04/01 | 1,524 | 1,528 | 1,511 | 1,511 | -1 | -0.1% | 47,000 |
| 2025/03/31 | 1,510 | 1,521 | 1,504 | 1,512 | -22 | -1.4% | 96,300 |
| 2025/03/28 | 1,540 | 1,550 | 1,525 | 1,534 | +5 | +0.3% | 186,800 |
| 2025/03/27 | 1,522 | 1,529 | 1,510 | 1,529 | +7 | +0.5% | 93,000 |
| 2025/03/26 | 1,507 | 1,528 | 1,503 | 1,522 | +7 | +0.5% | 69,700 |
| 2025/03/25 | 1,513 | 1,523 | 1,501 | 1,515 | +11 | +0.7% | 116,000 |
| 2025/03/24 | 1,490 | 1,510 | 1,486 | 1,504 | +16 | +1.1% | 86,500 |
| 2025/03/21 | 1,474 | 1,495 | 1,473 | 1,488 | +25 | +1.7% | 98,100 |
| 2025/03/19 | 1,459 | 1,473 | 1,459 | 1,463 | +4 | +0.3% | 57,900 |
| 2025/03/18 | 1,460 | 1,472 | 1,457 | 1,459 | +9 | +0.6% | 76,000 |
| 2025/03/17 | 1,449 | 1,461 | 1,446 | 1,450 | +4 | +0.3% | 57,800 |
| 2025/03/14 | 1,444 | 1,450 | 1,438 | 1,446 | -1 | -0.1% | 46,000 |
| 2025/03/13 | 1,452 | 1,462 | 1,446 | 1,447 | -2 | -0.1% | 60,300 |
| 2025/03/12 | 1,453 | 1,460 | 1,445 | 1,449 | +4 | +0.3% | 51,900 |
| 2025/03/11 | 1,445 | 1,451 | 1,435 | 1,445 | -12 | -0.8% | 94,400 |
1～
50
件表示中 / 2302件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ミズホメディ | 150,100円 | +1.2% | -13.9% | 5.66% | 8.85倍 | 1.65倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| 富士製薬 | 128,500円 | +15.7% | +5.3% | 3.54% | 9.29倍 | 0.69倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| ダイト | 205,700円 | +4.5% | -33.7% | 3.40% | 20.56倍 | 0.59倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| ＣＡＮＢＡＳ | 128,100円 | - | - | 0.00% | - | 8.20倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| アンジェス | 6,800円 | +110.0% | - | 0.00% | - | 11.20倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
市場注目の銘柄
チャート関連のコラム
